MTOR and esophageal squamous cell carcinoma: By integrating the outcome data from all the currently available studies, our meta-analysis showed that mTOR could be a strong biomarker for poor prognosis of ESCC, because that a prognostic marker would be considered of high predictive value for the negative prognosis if its HR value was larger than 2 [25, 28].